Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups. Fuji S, Tokunaga M, Utsunomiya A, Makiyama J, et al. Ann Hematol 2025;104:2429-2436.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fuji S, Tokunaga M, Utsunomiya A, Makiyama J, et al. Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups. Ann Hematol 2025;104:2429-2436.
PMID: 40133631